Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NextCure, Inc. (NXTC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.8100+0.0300 (+1.08%)
At close: 04:00PM EDT
2.8900 +0.08 (+2.85%)
After hours: 04:35PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close2.7800
Open2.7100
Bid2.7700 x 800
Ask2.8900 x 1000
Day's Range2.7100 - 2.8332
52 Week Range2.6600 - 9.1800
Volume59,466
Avg. Volume115,136
Market Cap77.974M
Beta (5Y Monthly)-0.09
PE Ratio (TTM)N/A
EPS (TTM)-2.6570
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.33
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NXTC

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NextCure, Inc.
    Market Update: AMGN, CMG, D, LEN, RLStocks continued to drop on Friday morning on interest rate and recession fears, led by sharp declines in the Energy, Materials, and Consumer Discretionary sectors. Goldman Sachs cut its year-end target for the S&P 500 by 16% to 3,600, citing a higher than previously expected path for interest rates. On the earnings front, Costco posted better-than-expected fiscal 4Q results, though the shares fell on concerns about declining gross margins. The Dow fell 1.4%, the S&P 1.7%, and the Nasdaq 1.9%. Crude oil dropped more than 5% to $79 per barrel, while gold traded near $1653 per ounce.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • GlobeNewswire

    NextCure to Present at the Ladenburg Thalmann Healthcare Conference

    BELTSVILLE, Md., Sept. 22, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the Ladenburg Thalmann Healthcare Conference in New York City on Thursday, September 29th at 10 am ET. A live audio webcast will be available through the Investors section of the company’s website at www.n

  • Simply Wall St.

    With 37% ownership, NextCure, Inc. (NASDAQ:NXTC) has piqued the interest of institutional investors

    To get a sense of who is truly in control of NextCure, Inc. ( NASDAQ:NXTC ), it is important to understand the...

  • GlobeNewswire

    NextCure Provides Business Update and Reports Second Quarter 2022 Financial Results

    On track to report data from all three clinical programsSecond quarter ending cash of $185.5 million expected to fund operations into the first quarter of 2024 BELTSVILLE, Md., Aug. 04, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today reported second quarter 2022 financial results and provided a business update. “

Advertisement
Advertisement